AzTrials
AzTrials

Orthopedic DisorderSSCuFFNCT06002009

SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function

An observational study of Orthopedic Disorder, run by University Hospitals of North Midlands NHS Trust at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objective of the study is to determine in adult patients with a rotator cuff tear, what size and pattern of rotator cuff tear would result in damage to the suprascapular nerve. The secondary objectives are 1. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Orthopedic Disorder
What is being tested?
MRI and Nerve conduction study
Type of treatment
Surgery or procedure
How many people
250 participants
Where
1 siteUnited Kingdom
Study dates
23 Jun 2025to 30 Sep 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participants will be recruited from the University Hospitals of North Midlands outpatient clinic

Who may be able to join

  • All patients age ≥18 years presenting to a UHNM shoulder clinic with a confirmed diagnosis of a rotator cuff tear (affecting one or both shoulders).

Who cannot join

  • Bony pathology (such as significant shoulder arthritis that would exclude isolated rotator cuff repair)
  • Grossly abnormal shoulder anatomy
  • Motor Neurone Disease
  • Cervical cord disease affecting the SSN nerve roots
  • Patients unable to undergo MRI scan
  • Previous surgery at the affected glenohumeral joint
Show all 11Show fewer
  • Patients unable to tolerate NCS
  • Acute fracture affecting the glenohumeral joint
  • Recent glenohumeral joint dislocation (past 12 months)
  • Patients unable or unwilling to give full informed consent
  • Patients unable or unwilling to comply with the study procedures

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site, 1 recruiting
  • University Hospitals of North Midlands NHS Trust

    Stoke-on-Trent

    Megan Young, 01782675384, megan.young@uhnm.nhs.uk

    Damian McClelland

    Recruiting

Other trials in United Kingdom

About this study

The primary objective of the study is to determine in adult patients with a rotator cuff tear, what size and pattern of rotator cuff tear would result in damage to the suprascapular nerve.

The secondary objectives are

  1. To determine if an injured suprascapular nerve can recover if the rotator cuff tear is surgically repaired.
  2. To determine if there is a limit of retraction before the suprascapular nerve is irreversibly damaged.
  3. To determine factors that are protective against SSN injury.
  4. Can the patient data gathered be used to optimise operative procedures.
Being tested
MRI, Nerve conduction study
Keywords
Rotator cuff tear, Suprascapular nerve function
Medical subject headings
Musculoskeletal Diseases, Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIRadiation

    MRI of shoulder

  • Nerve conduction studyOther

    Nerve conduction study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess suprascapular nerve funaction

    MRI scan to quantify size of rotator cuff tear, compared with Nerve Conduction Studies (NCS) to assess suprascapular nerve function.

    Measured: 36 months

Secondary outcomes (4)
  1. Shoulder scores

    Compare functional shoulder scores to the degree of nerve injury and muscle degeneration over a 24-month period post-injury. Scores to include active range of movement (ROM) measurements; and the collection of validated shoulder outcome scores (DASH, OSS, \& Constant score).

    Measured: 36 months

  2. Nerve recovery

    Functional assessment of nerve recovery at 24 months post-injury for surgically repaired rotator cuff tears.

    Measured: 24 months

  3. Machine learning

    Use of machine learning to investigate data set for optimum parameters or predictors

    Measured: 24 months

  4. Nerve conduction studies

    Repeat Nerve Conduction Study investigations at 12 months post injury for all surgically managed participants and non-surgical patients to assess suprascapular nerve function

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start23 Jun 2025
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion30 Sep 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06002009
Sponsor's protocol ID
3103
Acronym
SSCuFF
Status last verified
Aug 2025
First submitted
8 Aug 2023
Last updated
3 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Orthopedic Disorder, run by University Hospitals of North Midlands NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Megan Young (01782 675384, megan.young@uhnm.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess suprascapular nerve funaction (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2025; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in